In conclusion, this study demonstrates that SRC‐1 promotes HCC metastasis via enhancing MMP‐9 expression, indicating that inhibition of SRC‐1 may be an efficient therapeutic strategy for controlling HCC metastasis. The gene discussed is MMP9; the disease is hepatocellular carcinoma.